Atlas of Genetics and Cytogenetics in Oncology and Haematology


Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

X Y 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 NA

IGF2R insulin-like growth factor 2 receptor

Identity

Other namesM6P/IGF2R
HGNC (Hugo) IGF2R
Location 6q25-q27
Location_base_pair Starts at 160412295 and ends at 160526531 bp from pter ( according to hg19-Feb_2009)  [Mapping]

DNA/RNA

Note no known splice variants
Description 138376 bp
Transcription 9090 bp mRNA
Pseudogene None known

Protein

Description 2491 aa
Expression Subject to parental genomic imprinting in some viviparous mammals. Preferential transcription of maternally-derived allele in some mammals with the exception of primates and close relatives. Humans harbor a parentally imprinted differentially methylated CpG island, but human IGF2R transcripts are not preferentially maternally derived.
Function M6P/IGF2R translates to a protein whose diverse functions include lysosomal enzyme trafficking, fetal organogenesis, tumor suppression, and cytotoxic T-cell induced apoptosis. The M6P- and IGF2-binding sites are distinct within the protein, and are thought to have evolved independently, partly explaining the gamut of functions attributable to a single protein: the ancestral M6PR dates back at least 450 million years, and appears to have been a suitable platform for acquiring an IGF2 binding function in ancestral mammals roughly 150 to 200 million years ago; as with M6P-tagged molecules, bound IGF2 is targeted to lysosomes, where IGF2 is degraded. To the extent that the tumor suppressor role of M6P/IGF2R relies on IGF2 binding, the M6P/IGF2R is a very young tumor suppressor.
Homology CD-MPR

Mutations

Note Include genetic and epigenetic derangements.
Epigenetics Beyond biochemical and DNA sequence properties, M6P/IGF2R epigenetic traits have been described. In humans, there is a differentially methylated region (DMR) in intron 2 of the gene which is preferentially methylated on the maternally inherited copy of the gene; in addition, the human M6P/IGF2R resides in an asynchronously replicating genomic region, such that the gene allele inherited from the mother replicates first.

Despite these parentally pre-programmed epigenetic behaviors, human M6P/IGF2R transcription appears to be equivalent between both parentally-inherited alleles. Thus, human M6P/IGF2R alleles are encoded with information about parental origin, but this information is evidently uncoupled from transcriptional ramifications. This uncoupling is particularly intriguing in light of mouse genetic manipulations which causally link an imprinted M6p/igf2r DMR to imprinted transcription. Thus, the human M6P/IGF2R provides a rare example of uncoupling of stable gene imprinting --evidenced by somatically heritable parent-specific DNA methylation-- from stable imprinted transcription. Interestingly, the marsupial M6P/IGF2R homologue manifests parentally imprinted maternal transcription in the absence of imprinted differential methylation.

M6P/IGF2R, thus, is remarkably divergent across animal species with respect to both biochemical and epigenetic properties. Within the imprinted family of genes, M6P/IGF2R manifests a distinctive uncoupling of imprinted methylation from imprinted transcription, which frustrates efforts to establish the precise role of DNA methylation in the imprinting process. M6P/IGF2R is somewhat of a devil's advocate and a reminder that genes don't always read the journals.

Germinal Epigenetic alterations associated with fetal developmental abnormalities.
Somatic PCR-platform IGF2R LOH, microsatellite instability, and point mutations described in tumors.
Somatic mutations of M6P/IGF2R DNA sequence have been identified in human colon, liver, lung, breast and ovarian cancers, suggestive of Knudson-type two-hit oncogenetics at first glance; however, M6P/IGF2R loss of heterozygosity (LOH) is reported to precede point mutation of the remaining allele in the hepatocellular carcinoma model, in distinction from RB and other genes following the two-hit principle of Knudson. Statistically significant differences in M6P/IGF2R allelic variants have been identified between Japanese and American populations, but any functional significance has not been ascribed.

Implicated in

Entity Development, immunity, tumorigenesis.
  

External links

Nomenclature
HGNC (Hugo)IGF2R   5467
Entrez_Gene (NCBI)IGF2R  3482  insulin-like growth factor 2 receptor
Cards
AtlasIGF2RID380
GeneCards (Weizmann)IGF2R
Ensembl (Hinxton)ENSG00000197081 [Gene_View]  IGF2R [Vega]
AceView (NCBI)IGF2R
Genatlas (Paris)IGF2R
euGene (Indiana)3482
SOURCE (Stanford)NM_000876
Gene Expression (Array Express) ENSG00000197081
Genomic and cartography
GoldenPath (UCSC)IGF2R  -     chr6:160412295-160526531 +  6q26   [Description]    (hg19-Feb_2009)
EnsemblIGF2R - 6q26 [CytoView]
Mapping of homologs : NCBIIGF2R [Mapview]
OMIM147280   
Gene and transcription
Gene : Genbank (Entrez)AB209668 AK300848 BC172256 J03528 Y00285
Reference sequence (RefSeq transcript) :SRSNM_000876
Reference transcript : EntrezNM_000876
RefSeq genomic : SRSAC_000049 AC_000138 NC_000006 NG_011785 NT_025741 NW_001838991 NW_923184
RefSeq genomic : EntrezAC_000049 AC_000138 NC_000006 NG_011785 NT_025741 NW_001838991 NW_923184
Consensus coding sequences : CCDS NCBIIGF2R
Cluster EST : UnigeneHs.487062 [ SRS ] Hs.487062 [ NCBI ]
Alternative Splicing : Fast-db (Paris)16951
Protein : pattern, domain, 3D structure
Protein : UniProt/SwissProtP11717 (SRS) P11717 (Expasy) P11717 (Uniprot)
With graphics : InterProP11717
Splice isoforms : VarSplice FASTAP11717(VarSplice FASTA)
Domaine pattern : Prosite (SRS)FN2_1 (PS00023)    FN2_2 (PS51092)   
Domain pattern : Prosite (Expaxy)FN2_1 (PS00023)    FN2_2 (PS51092)   
Domains : Interpro (SRS)CIMR    FN_type2_col-bd    Kringle-like    Man6P_isomerase_rcpt-bd   
Domains : Interpro (EBI)CIMR    FN_type2_col-bd    Kringle-like    Man6P_isomerase_rcpt-bd   
Related proteins : CluSTrP11717
Domain families : Pfam SRSCIMR (PF00878)    fn2 (PF00040)   
Domain families : Pfam SangerCIMR (PF00878)    fn2 (PF00040)   
Domain families : Pfam NCBIpfam00878    pfam00040   
Domain families : Smart EMBLFN2 (SM00059)  
Blocks (Seattle)P11717
Crystal structure of protein : PDB SRS1E6F    1GP0    1GP3    1GQB    1JWG    1LF8    2CNJ    2V5N    2V5O    2V5P   
Crystal structure of protein : PDBSum1E6F    1GP0    1GP3    1GQB    1JWG    1LF8    2CNJ    2V5N    2V5O    2V5P   
Crystal structure of protein : IMB1E6F    1GP0    1GP3    1GQB    1JWG    1LF8    2CNJ    2V5N    2V5O    2V5P   
Crystal structure of protein : PDB RSDB1E6F    1GP0    1GP3    1GQB    1JWG    1LF8    2CNJ    2V5N    2V5O    2V5P   
Human Protein AtlasENSG00000197081
HPRD00928
Protein Interaction databases
DIP (DOE-UCLA)P11717
IntAct (EBI)P11717
FunCoupENSG00000197081
Polymorphism : SNP, mutations, diseases
Single Nucleotide Polymorphism (SNP) : dbSNP NCBIIGF2R
SNP : GeneSNP UtahIGF2R
SNP : HGBaseIGF2R
Genetic variants : HAPMAPIGF2R
Somatic Mutations in Cancer : COSMICIGF2R 
Mutations and Diseases : HGMDIGF2R
Hereditary diseases : OMIM147280   
Hereditary diseases : GENETests147280   
Diseases : Genetic AssociationIGF2R
General knowledge
Homologs : HomoloGeneIGF2R
Homology/Alignments : Family Browser UCSCIGF2R
Phylogenetic Trees/Animal Genes : TreeFamIGF2R
Chemical/Protein Interactions : CTD3482
Keywords Ontology : AmiGOliver development  glycoprotein binding  G-protein alpha-subunit binding  retinoic acid binding  receptor activity  G-protein coupled receptor activity  insulin-like growth factor receptor activity  transporter activity  protein binding  mannose binding  extracellular space  membrane fraction  nucleus  nuclear envelope lumen  cytoplasm  lysosomal membrane  endosome  trans-Golgi network  integral to plasma membrane  receptor-mediated endocytosis  signal transduction  spermatogenesis  post-embryonic development  cell surface  membrane  enzyme binding  endocytic vesicle  trans-Golgi network transport vesicle  organ regeneration  insulin-like growth factor II binding  response to retinoic acid  positive regulation of apoptosis  perinuclear region of cytoplasm  phosphoprotein binding  
Keywords Ontology : EGO-EBIliver development  glycoprotein binding  G-protein alpha-subunit binding  retinoic acid binding  receptor activity  G-protein coupled receptor activity  insulin-like growth factor receptor activity  transporter activity  protein binding  mannose binding  extracellular space  membrane fraction  nucleus  nuclear envelope lumen  cytoplasm  lysosomal membrane  endosome  trans-Golgi network  integral to plasma membrane  receptor-mediated endocytosis  signal transduction  spermatogenesis  post-embryonic development  cell surface  membrane  enzyme binding  endocytic vesicle  trans-Golgi network transport vesicle  organ regeneration  insulin-like growth factor II binding  response to retinoic acid  positive regulation of apoptosis  perinuclear region of cytoplasm  phosphoprotein binding  
Pathways : BIOCARTA
Pathways : KEGG
Other databases
Probes
Probes : ImagenesIGF2R Related clones (RZPD - Berlin)
Literature
PubMed114 Pubmed reference(s) in Entrez
PubGeneIGF2R

Bibliography

Structure and function of the mannose 6-phosphate/insulinlike growth factor II receptors.
Kornfeld S
Annual review of biochemistry. 1992 ; 61 : 307-330.
PMID 1323236
 
Conservation of a maternal-specific methylation signal at the human IGF2R locus.
Smrzka OW, Fa I, Stger R, Kurzbauer R, Fischer GF, Henn T, Weith A, Barlow DP
Human molecular genetics. 1995 ; 4 (10) : 1945-1952.
PMID 8595419
 
Imprinted expression of the Igf2r gene depends on an intronic CpG island.
Wutz A, Smrzka OW, Schweifer N, Schellander K, Wagner EF, Barlow DP
Nature. 1997 ; 389 (6652) : 745-749.
PMID 9338788
 
Loss of the gene encoding mannose 6-phosphate/insulin-like growth factor II receptor is an early event in liver carcinogenesis.
Yamada T, De Souza AT, Finkelstein S, Jirtle RL
Proceedings of the National Academy of Sciences of the United States of America. 1997 ; 94 (19) : 10351-10355.
PMID 9294214
 
Mannose 6-phosphate/insulin-like growth factor II receptor is a death receptor for granzyme B during cytotoxic T cell-induced apoptosis.
Motyka B, Korbutt G, Pinkoski MJ, Heibein JA, Caputo A, Hobman M, Barry M, Shostak I, Sawchuk T, Holmes CF, Gauldie J, Bleackley RC
Cell. 2000 ; 103 (3) : 491-500.
PMID 11081635
 
Divergent evolution in M6P/IGF2R imprinting from the Jurassic to the Quaternary.
Killian JK, Nolan CM, Wylie AA, Li T, Vu TH, Hoffman AR, Jirtle RL
Human molecular genetics. 2001 ; 10 (17) : 1721-1728.
PMID 11532981
 
Mannose 6-phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) variants in American and Japanese populations.
Killian JK, Oka Y, Jang HS, Fu X, Waterland RA, Sohda T, Sakaguchi S, Jirtle RL
Human mutation. 2001 ; 18 (1) : 25-31.
PMID 11438990
 
Epigenetic change in IGF2R is associated with fetal overgrowth after sheep embryo culture.
Young LE, Fernandes K, McEvoy TG, Butterwith SC, Gutierrez CG, Carolan C, Broadbent PJ, Robinson JJ, Wilmut I, Sinclair KD
Nature genetics. 2001 ; 27 (2) : 153-154.
PMID 11175780
 
Mannose 6-phosphate receptors: new twists in the tale.
Ghosh P, Dahms NM, Kornfeld S
Nature reviews. Molecular cell biology. 2003 ; 4 (3) : 202-212.
PMID 12612639
 
Familial aggregation of abnormal methylation of parental alleles at the IGF2/H19 and IGF2R differentially methylated regions.
Sandovici I, Leppert M, Hawk PR, Suarez A, Linares Y, Sapienza C
Human molecular genetics. 2003 ; 12 (13) : 1569-1578.
PMID 12812984
 
REVIEW articlesautomatic search in PubMed
Last year publicationsautomatic search in PubMed

Search in all EBI   NCBI

Contributor(s)

Written03-2004J Keith Killian

Citation

This paper should be referenced as such :
Killian JK . IGF2R insulin-like growth factor 2 receptor. Atlas Genet Cytogenet Oncol Haematol. March 2004 .
URL : http://AtlasGeneticsOncology.org/Genes/IGF2RID380.html

© Atlas of Genetics and Cytogenetics in Oncology and Haematology
indexed on : Tue Aug 31 20:10:14 CEST 2010

Home   Genes   Leukemias   Solid Tumours   Cancer-Prone   Deep Insight   Case Reports   Journals  Portal   Teaching   

For comments and suggestions or contributions, please contact us

jlhuret@AtlasGeneticsOncology.org.